Watch CBS News

Johnson & Johnson

cbsn-fusion-blood-clots-more-likely-in-people-with-covid-19-infections-than-vaccines-study-shows-thumbnail-693542-640x360.jpg

New study may shed light on COVID blood clots

Research from Oxford University in England has new data regarding the rate of blood clotting cases in COVID-19 patients and vaccine recipients. The study, which has not been peer-reviewed yet, shows that the particular blood clot which was studied is eight to ten times more common in people who experience a COVID-19 infection than in people who were inoculated. Dr. David Agus joins "CBS This Morning" to explain the latest development.

cbsn-fusion-coronavirus-vaccine-johnson-and-johnson-clotting-issue-analysis-dr-julie-morita-thumbnail-691821-640x360.jpg

How big of a concern is the J&J clotting issue?

The Biden administration says that pausing the distribution of Johnson & Johnson's coronavirus vaccine should not hamper the nation's ongoing vaccine efforts. As CBS News' Skyler Henry reports, the announcement comes as the U.S. calls to pause the distribution of the Johnson & Johnson vaccine after receiving reports that at least six women had suffered a rare blood-clotting disorder after getting their shot. Dr. Julie Morita, a former member of the Biden administration transition advisory board and the executive vice president of the Rober Wood Johnson Foundation, joins CBSN's Tanya Rivero to discuss the impact the pause could have on the nation's vaccine efforts.

Show More
View CBS News In
CBS News App Open
Chrome Safari Continue
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.